A study of lipid profile before and after coronary artery bypass grafting

被引:0
作者
Ooi, M [1 ]
Cooper, A [1 ]
Lloyd, G [1 ]
Jackson, G [1 ]
机构
[1] GUYS HOSP, DEPT CARDIOL, LONDON SE1 9RT, ENGLAND
来源
BRITISH JOURNAL OF CLINICAL PRACTICE | 1996年 / 50卷 / 08期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study was undertaken to establish the variability in the levels of total cholesterol (TC), total triglyceride (TG), low-density lipoprotein (LDL) cholesterol, and high-density lipoprotein (HDL) cholesterol before and after coronary artery bypass graft (CABG) surgery, in order to determine postoperatively when an accurate assessment can be made of the lipid status. During a prospective study over 4 months, fasting venous samples were taken pre- and postoperatively on day 5, and in the 4th, 8th and 12th weeks. Ninety-six patients admitted to the cardiothoracic and cardiac wards for CABG were recruited to the study. The mean preoperative levels were: TC 5.94 (+/- 0.1 mmol/l), LDL cholesterol 4.02 (+/- 0.05mmol/l) and HDL cholesterol 1.00 (+/- 0.03mmol/l). These were significantly different (p<0.01) from the levels on the 5th postoperative day when the mean level of TC was 4.14 (+/- 0.084mmol/l), LDD cholesterol was 2.45 (+/- 0.07mmol/l) and HDL cholesterol was 0.74 (+/- 0.03mmol/l). By the 4th postoperative week, mean TC (5.73 +/- 0.13mmol/l), LDL cholesterol (3.79 +/- 0.14mmol/l) and HDL cholesterol (1.03 +/- 0.04mmol/l) did not vary significantly from the mean preoperative values. There was no significant difference in the mean TG levels pre- and postoperatively. The mean TC, LDL cholesterol and HDL cholesterol rise to preoperative levels by the 4th week after CABG. Thus, an accurate assessment of patients' lipid status can be made from this period. An earlier postoperative assessment may be falsely reassuring.
引用
收藏
页码:433 / 435
页数:3
相关论文
共 11 条
  • [1] BENEFICIAL-EFFECTS OF COMBINED COLESTIPOL-NIACIN THERAPY ON CORONARY ATHEROSCLEROSIS AND CORONARY VENOUS BYPASS GRAFTS
    BLANKENHORN, DH
    NESSIM, SA
    JOHNSON, RL
    SANMARCO, ME
    AZEN, SP
    CASHINHEMPHILL, L
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (23): : 3233 - 3240
  • [2] EFFECTS OF COLESTIPOL-NIACIN THERAPY ON HUMAN FEMORAL ATHEROSCLEROSIS
    BLANKENHORN, DH
    AZEN, SP
    CRAWFORD, DW
    NESSIM, SA
    SANMARCO, ME
    SELZER, RH
    SHIRCORE, AM
    WICKHAM, EC
    [J]. CIRCULATION, 1991, 83 (02) : 438 - 447
  • [3] BENEFICIAL-EFFECTS OF COLESTIPOL-NIACIN ON CORONARY ATHEROSCLEROSIS - A 4-YEAR FOLLOW-UP
    CASHINHEMPHILL, L
    MACK, WJ
    POGODA, JM
    SANMARCO, ME
    AZEN, SP
    BLANKENHORN, DH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (23): : 3013 - 3017
  • [4] CHANGES IN TOTAL CHOLESTEROL AND HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL IN MEN AFTER CORONARY-ARTERY BYPASS-GRAFTING
    CUNNINGHAM, MJ
    BOUCHER, TM
    MCCABE, CH
    HOROWITIZ, GL
    PASTERNAK, RC
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1987, 60 (16) : 1393 - 1394
  • [5] DODDS C, 1959, LANCET, V1, P1160
  • [6] CHANGES IN CHOLESTEROL LEVELS AFTER CORONARY-ARTERY BYPASS-SURGERY
    FIGUEROA, O
    FRANCOSAENZ, R
    MULROW, PJ
    MONTESINOS, E
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1992, 303 (02) : 73 - 77
  • [7] FYFE T, 1971, LANCET, V2, P997
  • [8] GOREN J, 1952, VOEDING, V13, P556
  • [9] Mc Quarrie I, 1932, P SOC EXP BIOL MED, V29, P1281
  • [10] PEDERSEN TR, 1994, LANCET, V344, P1383